Skip to main content
. 2008 Dec 14;100(2):357–362. doi: 10.1111/j.1349-7006.2008.01047.x

Table 2a.

Adverse events occurring in 20% or more of patients

Adverse event SR29142
0.15 mg/kg (n = 25) 0.20 mg/kg (n = 25)
All gradesn (%) Grade 3/4n (%) All gradesn (%) Grade 3/4n (%)
White blood cells decreased 24 (96) 22 (88) 22 (88) 21 (84)
Neutrophil count decreased 22 (88) 22 (88) 19 (76) 19 (76)
Alopecia 20 (80)  0 (0) 18 (72)  0 (0)
Lymphocyte count decreased 16 (64) 15 (60) 18 (72) 15 (60)
Nausea 12 (48)  0 (0) 15 (60)  1 (4)
Constipation 10 (40)  4 (16) 11 (44)  3 (12)
Aspartate aminotransferase increased  6 (24)  0 (0) 11 (44)  1 (4)
Hemoglobin decreased 11 (44.0)  4 (16)  6 (24)  0 (0)
Platelet count decreased  8 (32)  4 (16)  9 (36)  3 (12)
Alanine aminotransferase increased  7 (28)  1 (4)  8 (32)  1 (4)
Anorexia  7 (28)  1 (4)  8 (32)  1 (4)
Malaise  7 (28)  0 (0)  8 (32)  0 (0)
Vomiting  6 (24)  0 (0)  9 (36)  0 (0)
Diarrhea  8 (32)  0 (0)  4 (16)  0 (0)
Hyperglycemia  6 (24)  2 (8)  5 (20)  1 (4)
Pyrexia  5 (20)  0 (0)  6 (24)  1 (4)
Stomatitis  3 (12)  0 (0)  8 (32)  1 (4)
Blood bilirubin increased  7 (28)  0 (0)  3 (12)  0 (0)
Blood lactate dehydrogenase increased  5 (20)  0 (0)  5 (20)  1 (4)